Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-02-19 Sale | 2021-02-23 2:30 pm | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 7,500 | $149.01 | $1,117,575 | 145,510 (Indirect Direct) | View |
2020-08-21 Sale | 2020-08-25 3:56 pm | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 5,000 | $86.57 | $432,850 | 147,510 (Indirect Direct) | View |
2020-05-18 Sale | 2020-06-03 4:26 pm | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 20,000 | $74.02 | $1,480,322 | 144,960 (Indirect Direct) | View |
2020-05-18 Sale | 2020-05-20 7:50 pm | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 7,500 | $74.65 | $559,875 | 165,960 (Indirect Direct) | View |
2018-12-14 Purchase | 2018-12-18 8:20 pm | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Aliski William Director | 6,000 | $3.2462 | $19,477 | 8,500 (Direct) | View |
2018-12-07 Sale | 2018-12-07 4:12 pm | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 6,000 | $49.69 | $298,140 | 162,960 (Indirect Direct) | View |
2018-11-08 Sale | 2018-11-08 6:47 pm | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 6,000 | $55.67 | $334,020 | 168,960 (Indirect Direct) | View |
2018-08-08 Sale | 2018-08-08 5:32 pm | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 3,750 | $76.66 | $287,475 | 72,610 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-11-30 Disposition | 2022-12-01 09:21 am | N/A 2028-09-20 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Aliski William Director | 71,000 | $0 | 0 (Direct) | View |
2022-11-30 Equity Swap | 2022-12-01 09:21 am | N/A N/A | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Aliski William Director | 8,500 | $0 | 0 (Direct) | View |
2022-06-06 Option Award | 2022-06-27 4:15 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Aliski William Director | 6,667 | $0 | 6,667 (Direct) | View |
2021-11-30 Option Award | 2021-12-02 6:43 pm | N/A 2031-11-30 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Aliski William Director | 14,000 | $0 | 14,000 (Direct) | View |
2021-06-24 Option Award | 2021-06-28 6:26 pm | N/A 2031-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 6,270 | $0 | 151,780 (Direct) | View |
2021-06-02 Option Award | 2021-06-02 5:03 pm | N/A 2031-06-02 | X4 Pharmaceuticals Inc | XFOR | Aliski William Director | 6,000 | $9.5 | 6,000 (Direct) | View |
2021-02-19 Exercise | 2021-02-23 2:30 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 7,500 | $97.85 | 145,510 (Direct) | View |
2021-02-19 Exercise | 2021-02-23 2:30 pm | N/A 2025-06-18 | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 7,500 | $0 | 145,510 (Direct) | View |
2021-02-23 Gift | 2021-02-23 2:30 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 1,000 | $0 | 145,510 (Direct) | View |
Ownership | 2021-02-03 8:02 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 0 | $0 | 146,510 (Indirect) | View |
2020-05-21 Ownership | 2021-02-03 8:02 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 2,000 | $0 | 146,510 (Direct) | View |
2020-12-16 Option Award | 2020-12-18 5:15 pm | N/A 2030-12-16 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Aliski William Director | 12,000 | $0 | 12,000 (Direct) | View |
2020-08-21 Exercise | 2020-08-25 3:56 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 5,000 | $58.74 | 147,510 (Direct) | View |
2020-08-21 Exercise | 2020-08-25 3:56 pm | N/A 2029-06-11 | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 5,000 | $0 | 147,510 (Direct) | View |
2020-06-26 Option Award | 2020-06-30 1:10 pm | N/A 2030-06-26 | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 6,800 | $0 | 151,760 (Direct) | View |
2020-06-10 Option Award | 2020-06-11 08:34 am | N/A 2030-06-09 | X4 Pharmaceuticals Inc | XFOR | Aliski William Director | 3,427 | $0 | 3,427 (Direct) | View |
2020-05-18 Exercise | 2020-05-20 7:50 pm | N/A 2024-07-10 | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 7,500 | $0 | 165,960 (Direct) | View |
2020-05-18 Exercise | 2020-05-20 7:50 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 7,500 | $40.37 | 165,960 (Direct) | View |
2019-12-04 Option Award | 2019-12-06 5:45 pm | N/A 2029-12-04 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Aliski William Director | 10,000 | $0 | 10,000 (Direct) | View |
2019-09-18 Option Award | 2019-09-20 4:52 pm | N/A 2029-09-18 | X4 Pharmaceuticals Inc | XFOR | Aliski William Director | 6,854 | $0 | 6,854 (Direct) | View |
2019-06-11 Option Award | 2019-06-13 5:00 pm | N/A 2029-06-11 | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 8,000 | $0 | 170,960 (Direct) | View |
2018-11-15 Option Award | 2018-11-19 7:26 pm | N/A 2028-11-15 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Aliski William Director | 10,000 | $0 | 10,000 (Direct) | View |
2018-09-20 Option Award | 2018-09-24 9:46 pm | N/A 2028-09-20 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Aliski William Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2018-09-24 9:37 pm | N/A N/A | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Aliski William Director | 0 | $0 | 2,500 (Direct) | View |
2018-06-19 Option Award | 2018-06-20 5:50 pm | N/A 2028-06-19 | Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director | 8,000 | $0 | 81,360 (Direct) | View |